Press release
Angiotensin Receptor Blockers (ARBs) Market Anticipated To Witness Robust Growth, Surpassing $10.76 Billion By 2029
Angiotensin Receptor Blockers (ARBs)
What Is the Current Angiotensin Receptor Blockers (ARBs) Market Size and Its Estimated Growth Rate?
There has been a consistent increase in the angiotensin receptor blockers (ARBs) market size over the past few years. The market, which was at $8.51 billion in 2024, is anticipated to escalate to $8.87 billion in 2025, showcasing a compound annual growth rate (CAGR) of 4.1%. This upward trajectory during the historical period is due to factors such as the surge in hypertension cases, proven clinical benefits, cardiovascular disease prevalence, protection against kidney diseases, defined clinical guidelines, the adoption of ARBs as the initial treatment approach, along with their cost-effectiveness.
The market size of angiotensin receptor blockers (ARBs) is anticipated to experience consistent expansion in the upcoming years, predicting to soar to $10.76 billion by 2029, with a compound annual growth rate (CAGR) of approximately 5.0%. Factors contributing to this growth during the projected span include methodologies of precision medicine, emphasis on combination therapies, global market growth, treatment strategies based on biomarkers, governmental initiatives, and heightened hypertension awareness. Further future trends include the embracing of telemedicine, investments in research and development, competition from generics and expiring patents, digital health aids for medication compliance, and competition from biosimilar compounds.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8943
How Are Emerging Segments Shaping the Angiotensin Receptor Blockers (ARBs) Market Landscape?
The angiotensin receptor blockers (ARBs) market covered in this report is segmented -
1) By Product: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan
2) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications
3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers
Subsegments:
1) By Valsartan: Tablets, Capsules, Injectable Forms
2) By Telmisartan: Tablets, Capsules
3) By Losartan: Tablets, Oral Solution
4) By Irbesartan: Tablets, Oral Solution
5) By Azilsartan: Tablets
6) By Olmesartan: Tablets, Oral Suspension
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8943&type=smp
Which Growth Factors Are Influencing Angiotensin Receptor Blockers (ARBs) Market Expansion?
The upward trend in cardiovascular disease prevalence is predicted to stimulate the expansion of the angiotensin receptor blockers market. Cardiovascular disease (CVD), a condition that impacts the heart and blood vessels, typically leads to the formation of fatty residues within the arteries (atherosclerosis) and a heightened probability of blood clots. By assisting in the relaxation of veins and arteries, angiotensin receptor blockers can decrease blood pressure and enhance the heart's ability to pump blood, thereby reducing the odds of cardiovascular disease. For example, in August 2022, the American College of Cardiology, a professional medical organization based in the US, predicted significant increases in cardiovascular risk factors and disease rates in the United States by 2060. Thus, the rising prevalence of cardiovascular diseases is fueling growth in the angiotensin receptor blockers market.
Who Are the Dominant Players Across Different Angiotensin Receptor Blockers (ARBs) Market Segments?
Major companies operating in the angiotensin receptor blockers (ARBs) market include Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca Plc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Lupin Limited, Dr. Reddy's Laboratories Ltd., Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific, Sanofi, Johnson & Johnson, Eli Lilly, Bayer AG, Abbvie Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Zydus Cadila, Glenmark Pharmaceuticals Ltd., Cipla Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zhejiang Huahai Pharmaceutical Co. Ltd., Boehringer Ingelheim Ltd., Astellas Pharma
What Are the Latest Developing Trends in the Angiotensin Receptor Blockers (ARBs) Market?
Top corporations operating in the angiotensin receptor blocker market are creating innovative products such as angiotensin receptor neprilysin inhibitors, aimed at boosting healthcare solutions and enhancing outcomes for cardiovascular patients. These inhibitors, known as ARNIs, are a group of drugs utilized in managing heart failure. Notably, in January 2023, Glenmark Pharmaceuticals, a business based in India, introduced sacubitril and valsartan tablets. These tablets are designed to treat heart failure, specifically aiming at heart failure with a reduced ejection fraction (HFrEF). These tablets are included in the ARNI (angiotensin receptor neprilysin inhibitors) medication class. Sacubitril boosts the natriuretic peptide (NP) system, which helps manage fluid overload and encourages blood vessel expansion, whereas valsartan impedes the renin-angiotensin system (RAS) to reduce blood pressure and lighten the heart's duty. Collectively, they effectively overcome heart failure symptoms, lower the danger of cardiovascular death, and diminish the probability of hospital admittance due to heart failure. Furthermore, these drugs are traded under the Sacu V brand.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/angiotensin-receptor-blockers-arbs-global-market-report
Which Geographic Regions Are Expected to Dominate the Angiotensin Receptor Blockers (ARBs) Market in the Coming Years?
North America was the largest region in the angiotensin receptor blockers (ARBs) market share in 2024. The regions covered in the angiotensin receptor blockers (ARBs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Angiotensin Receptor Blockers (ARBs) Market?
2. What is the CAGR expected in the Angiotensin Receptor Blockers (ARBs) Market?
3. What Are the Key Innovations Transforming the Angiotensin Receptor Blockers (ARBs) Industry?
4. Which Region Is Leading the Angiotensin Receptor Blockers (ARBs) Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Angiotensin Receptor Blockers (ARBs) Market Anticipated To Witness Robust Growth, Surpassing $10.76 Billion By 2029 here
News-ID: 3976900 • Views: …
More Releases from The Business Research Company
Key Trends Reshaping the Agricultural Biotechnology Market: Innovative Biotechno …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Agricultural Biotechnology Market Size Growth Forecast: What to Expect by 2025?
In recent times, the agricultural biotechnology market has witnessed considerable growth. It is anticipated to expand from $44.82 billion in 2024 to $49.18 billion in 2025, at a Compound Annual Growth Rate (CAGR) of 9.7%. This significant increase…
Health-Conscious Trends Propel Growth In Sorghum Seed Market: Transformative For …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Sorghum Seed Industry Market Size Be by 2025?
Over recent years, the sorghum seed market has experienced a significant uptick in growth. The market is projected to escalate from a value of $2.06 billion in 2024 to $2.18 billion in 2025, advancing at a compound annual…
Steady Expansion Forecast for Meat Market, Projected to Reach $1599.32 Billion b …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Meat Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The expansion of the meat market has been robust in the last few years. The market which is projected to be at $1133.29 billion in 2024 is expected to escalate to $1217.95 billion in 2025 with…
Grain Farming Industry Outlook 2025-2029: Market Set to Cross $1633.78 Billion M …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Grain Farming Market Size By 2025?
In the past few years, the size of the grain farming market has significantly expanded. It is projected to rise from $1139.2 billion in 2024 to $1226.32 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.6%.…
More Releases for ARBs
Angiotensin Receptor Blockers (ARBs) Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Angiotensin Receptor Blockers (ARBs) Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The Angiotensin Receptor Blockers (ARBs) market has been expanding steadily due to their widespread use in the treatment of hypertension, heart failure, and…
Angiotensin Receptor Blockers (ARBs) Market Current Status and Future Prospects …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Angiotensin Receptor Blockers (ARBs) Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The impact of manufacturers on the market is significant across various industries, influencing supply chains, consumer choices, and economic growth. Manufacturers are key…
Angiotensin Receptor Blockers (ARBs) Market Trends, Strategies, Size, Share And …
"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Angiotensin Receptor Blockers (ARBs) Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $10.28 billion In…
Angiotensin Receptor Blockers (ARBs) Market size, Share, Trends, Drivers And For …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
The Business Research Company's Angiotensin Receptor Blockers (ARBs) Global Market Report 2023 identifies the increasing incidence of cardiovascular diseases as the major driver for the angiotensin receptor blockers (ARBs) market's growth in the forecast period. It is frequently associated with the development of fatty deposits within the…
Angiotensin Receptor Blockers (Arbs) Market Size, Share, Growth Report 2023
The global angiotensin receptor blockers (arbs) market size was valued at USD 8,049.9 million in 2022 and is poised to grow at a significant CAGR of 3.9% during the forecast period 2023-29. The primary drivers of the expansion of the global angiotensin receptor blockers market include the increasing prevalence of cardiovascular diseases and chronic kidney disorders. In addition, increasing geriatric population is expected to boost the growth of angiotensin receptor…
Angiotensin Receptor Blockers (ARBs) Market 2022 | Detailed Report
The top-notch information research report published by markets and markets is a vital asset that offers qualitative and quantitative factors of the Angiotensin Receptor Blockers (ARBs) market. The research study and methodologies mentioned in the report examine the critical vendors by considering their contribution to the global market. Furthermore, the report offers an in-depth insight into leading players' performance based on revenue generation and client requirements. Also, the research report…
